The effectiveness of anakinra to fight arthritis

The anakinra is a drug indicated for the treatment of rheumatoid arthritis that does not respond to treatment with methotrexate. It is also used in combination with this drug. It owes its effectiveness to the ability to block inflammation and degradation of the cartilage .

Anakinra is not considered a disease-modifying antirheumatic drug (DMARD), but rather is a biological response modifier (BRM). That belongs to this second classification is because it is capable of selectively attacking the pathological element of the disease.

To better understand and understand the mechanism by which anakinra is effective against this disease, we must first have a basic idea of ​​what arthritis is.

How does arthritis develop?

The effectiveness of anakinra to fight arthritis

Arthritis is a autoimmune disease characterized by persistent inflammation in the joints. It usually affects small joints, such as, for example, the hands and feet.

In the affected places, this disease it produces a progressive destruction and generates different degrees of deformity and functional disability. Cursa, apart from inflammation, with pain, stiffness and loss of joint function.

Although the exact cause is not known, Yes, it is known that autoimmunity is fundamental for the development, origin and progression of arthritis. This means that the disease is the result of an attack by our immune system to the tissues of the body.

This process is associated with presence of autoantibodies , which are proteins developed by the immune system that act directly on our own body. It usually begins in middle age but is more common among older adults. It can also affect other parts of the body as well as the joints, such as the eyes, mouth and lungs.

Now We will see in more detail the following sections about the anakinra:

  • Mechanism of action.
  • Pharmacokinetics
  • Adverse reactions.

Mechanism of action

The anakinra is a 1α receptor antagonist and 1β of interleukin (IL-1). It competitively inhibits the binding of interleukin-1 to its receptor, which is expressed in a wide variety of tissues and organs.

IL-1 occurs in response to inflammatory stimuli and mediates different physiological responses. Within them are the inflammatory and immunological reactions. This protein also stimulates bone resorption and causes tissue damage such as cartilage degradation, which is why it is effective in rheumatoid arthritis.

Anakinra pharmacokinetics

The effectiveness of anakinra to fight arthritis

This drug is administered subcutaneously presenting a good absorption. It must always be administered at the same time to avoid the accumulation of the drug. It has an elimination half-life of approximately 4 to 6 hours.

Is excreted mainly by urinary tract. This elimination is variable depending on the clearance of creatinine and the patient’s body weight. Creatinine is a waste product of our body that is filtered in the liver and then eliminated in the urine. Measuring their clearance is a very common process to check the functioning of the kidneys in patients.

In those that this value is increased, like the corporal weight, the clearance of the anakinra will also be greater. The clearance is the amount of plasma that the liver can purify per unit of time.

Present a bioavailability, after administering a dose of 70 mg, 95% and the maximum concentrations in plasma in patients with rheumatoid arthritis appear between 3 and 7 hours after the administration of a dose of 1-2mg / kg of drug.

Adverse reactions

The effectiveness of anakinra to fight arthritis

The most frequent adverse reaction of this medicine is a reaction that occurs in the place where you have injected the corresponding dose. This reaction appears in almost all patients treated with anakinra.

Apart from this symptom, there are other adverse reactions typical of this drug. First of all mention the gastrointestinal discomfort that can occur, such as nausea, diarrhea or abdominal pain.

On the other hand, it is possible that it triggers allergic reactions, the use of anakinra in patients hypersensitive to the drug is prohibited. There have also been cases in which patients have suffered neurological problems.

An important adverse reaction is the hematological problems (affects the blood cells) that can densencadenar. Other effects of the anakinra are:

Facebook Comments